Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy PetIQ stock | 27.5

Own PetIQ stock in just a few minutes.

Posted

Fact checked

PetIQ, Inc is a drug manufacturers—specialty & generic business based in the US. PetIQ shares (PETQ) are listed on the NASDAQ and all prices are listed in US Dollars. PetIQ employs 1,866 staff and has a trailing 12-month revenue of around USD$794.1 million.

How to buy shares in PetIQ

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for PetIQ. Find the stock by name or ticker symbol: PETQ. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until PetIQ reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$27.5, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of PetIQ, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of PetIQ. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted PetIQ's share price?

Since the stock market crash in March caused by coronavirus, PetIQ's share price has had significant negative movement.

Its last market close was USD$27.5, which is 20.89% down on its pre-crash value of USD$34.76 and 73.72% up on the lowest point reached during the March crash when the shares fell as low as USD$15.83.

If you had bought USD$1,000 worth of PetIQ shares at the start of February 2020, those shares would have been worth USD$600.84 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$917.95.

PetIQ share price

Use our graph to track the performance of PETQ stocks over time.

PetIQ shares at a glance

Information last updated 2020-10-14.
Latest market close USD$27.5
52-week range USD$15.83 - USD$38.99
50-day moving average USD$32.5313
200-day moving average USD$30.7632
Wall St. target price USD$44.4
PE ratio 134.359
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.195

Buy PetIQ shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy PetIQ stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PetIQ price performance over time

Historical closes compared with the close of $27.5 from 2020-11-16

1 week (2020-11-16) 27.5
1 month (2020-10-26) -6.81%
3 months (2020-08-24) -12.03%
6 months (2020-05-22) -4.58%
1 year (2019-11-22) 19.98%
2 years (2018-11-23) -6.97%
3 years (2017-11-24) 24.43%
5 years (2015-11-22) N/A

Is PetIQ under- or over-valued?

Valuing PetIQ stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PetIQ's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

PetIQ's P/E ratio

PetIQ's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 134x. In other words, PetIQ shares trade at around 134x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

PetIQ's PEG ratio

PetIQ's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2396. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PetIQ's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

PetIQ's EBITDA

PetIQ's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$37.3 million.

The EBITDA is a measure of a PetIQ's overall financial performance and is widely used to measure a its profitability.

PetIQ financials

Revenue TTM USD$794.1 million
Operating margin TTM 2.21%
Gross profit TTM USD$118.7 million
Return on assets TTM 1.58%
Return on equity TTM -7.74%
Profit margin -2.63%
Book value $13.084
Market capitalisation USD$930.9 million

TTM: trailing 12 months

Shorting PetIQ shares

There are currently 5.2 million PetIQ shares held short by investors – that's known as PetIQ's "short interest". This figure is 3.5% down from 5.4 million last month.

There are a few different ways that this level of interest in shorting PetIQ shares can be evaluated.

PetIQ's "short interest ratio" (SIR)

PetIQ's "short interest ratio" (SIR) is the quantity of PetIQ shares currently shorted divided by the average quantity of PetIQ shares traded daily (recently around 276673.20954907). PetIQ's SIR currently stands at 18.85. In other words for every 100,000 PetIQ shares traded daily on the market, roughly 18850 shares are currently held short.

However PetIQ's short interest can also be evaluated against the total number of PetIQ shares, or, against the total number of tradable PetIQ shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PetIQ's short interest could be expressed as 0.18% of the outstanding shares (for every 100,000 PetIQ shares in existence, roughly 180 shares are currently held short) or 0.2898% of the tradable shares (for every 100,000 tradable PetIQ shares, roughly 290 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against PetIQ.

Find out more about how you can short PetIQ stock.

PetIQ share dividends

We're not expecting PetIQ to pay a dividend over the next 12 months.

PetIQ share price volatility

Over the last 12 months, PetIQ's shares have ranged in value from as little as $15.83 up to $38.99. A popular way to gauge a stock's volatility is its "beta".

PETQ.US volatility(beta: 1.56)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PetIQ's is 1.5554. This would suggest that PetIQ's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

PetIQ overview

PetIQ, Inc. operates as a pet medication and wellness company. It operates through two segments, Products and Services. The company offers prescription pet medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; and over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars. It also provides health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products The company offers its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers across 41 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. As of March 10, 2020, it operated through approximately 60,000 points of distribution across retail and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site